Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind randomized crossover trial of AZD4282 in postherpetic neuralgia
2004-004908-21Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AZD4282 in postherpetic neuralgia (PHN) (2 arms), sponsored by AstraZeneca. Primary endpoint: Change in mean 24-hour average pain intensity. Started Jan 2005; status: completed.
02
Drugs
AZD4282
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on 2004-004908-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004908-21.